CAF (Cancer-Associated Fibroblast)

Back to Wiki

tumor-microenvironment

Cancer-associated fibroblasts (CAFs) are activated, fibroblast-like stromal cells within the tumor microenvironment that remodel the extracellular matrix, contribute to fibrosis, and modulate the behavior of nearby tumor and immune cells. They are commonly identified by markers such as α-SMA, FAP, vimentin, and DESMIN, and represent a major component of the tumor stroma across many solid cancers.

CAF populations are heterogeneous — different marker-defined subsets (e.g., DESMIN+, GPR77+/CD10+, LRRC15+, POSTN+ CAFs) have been linked to distinct functional roles, including cytokine secretion, chemoresistance, and immune suppression. Single-cell studies across tumor types broadly converge on a myofibroblastic and an inflammatory subtype, with an antigen-presenting subtype in some organs.

CAFs arise by co-option of the fibroblast activation program that normally serves tissue repair, driven both by mechanical stress and by paracrine signals from cancer and immune cells. Their two broad functions in the tumor microenvironment are matrix production and remodeling — which raises tissue stiffness, opens invasion tracks, and physically limits drug and lymphocyte access — and immune modulation, through recruitment of myeloid cells (IL-1α/β, CXCL1, CXCL12, G-CSF, IL-6), polarization of macrophages toward pro-tumor states, inhibition of CD8+ T cell function, and suppression of NK cell activation via PGE2 and IDO.

Because the available markers are shared with pericytes, mesothelial and endothelial cells, and because CAF states interconvert, attempts to target CAFs by depleting a marker-defined population have produced opposite results: depleting FAP+ cells promoted immune-mediated tumor control and synergy with checkpoint blockade, whereas depleting αSMA+ cells in a murine pancreatic model reduced survival and increased regulatory T cells.

Source papers

  • Stromal-Derived IL-8 Promotes M2 Macrophage Polarization via the RhoA/MRTF-A/SRF Transcriptional Axis to Impair CD8+ T Cell Cytotoxicity in Lung Cancer Xuyu Gu, Qiyu Fang, Jia Yu, Ting Yu, Huashan Shi, Kaiqi Jin, Lei Jiang, Wentian Zhang · 2026 doi:10.1002/advs.202508001
  • Activated fibroblasts in cancer: Perspectives and challenges Giuseppina Caligiuri, David A. Tuveson · 2023 doi:10.1016/j.ccell.2023.02.015
  • Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in pancreatic ductal adenocarcinoma Xinxin Liu, Zhihua Huang, Bohan Yang, et al., Xiaojie Xu, Yinmo Yang · 2026 doi:10.1038/s41467-026-75772-5